Evaluation of beta-endorphin/beta-lipotropin immunoreactivity content in the CSF of patients affected by deafferentation pain syndromes.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 1829520)

Published in Pharmacol Res on February 01, 1991

Authors

G Salar1, L Alessio, S Govoni, F Battaini, I Iob, I Goss, M Trabucchi

Author Affiliations

1: Institute of Neurosurgery, University of Padua.

Articles by these authors

Atrial fibrillation and cognitive disorders in older people. J Am Geriatr Soc (2000) 3.59

Association of apolipoprotein E E4 with vascular dementia. JAMA (1994) 2.48

Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial. Aging Ment Health (2010) 2.46

Differential level of platelet amyloid beta precursor protein isoforms: an early marker for Alzheimer disease. Arch Neurol (1998) 2.38

Sensory impairment and quality of life in a community elderly population. J Am Geriatr Soc (1993) 2.02

Wild-type huntingtin protects from apoptosis upstream of caspase-3. J Neurosci (2000) 1.92

Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J (1998) 1.86

Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer's disease. Neurology (1999) 1.78

Linear measures of atrophy in mild Alzheimer disease. AJNR Am J Neuroradiol (1996) 1.74

Object and action naming in Alzheimer's disease and frontotemporal dementia [see comment]. Neurology (1998) 1.71

Reliability of urinary creatinine as a parameter used to adjust values of urinary biological indicators. Int Arch Occup Environ Health (1985) 1.70

Mini-Mental State Examination: a normative study in Italian elderly population. Eur J Neurol (1996) 1.60

Calcium responses in human fibroblasts: a diagnostic molecular profile for Alzheimer's disease. Neurobiol Aging (1996) 1.59

Role of brain allopregnanolone in the plasticity of gamma-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc Natl Acad Sci U S A (1998) 1.58

Long-term exposure to "low levels" of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology (1999) 1.56

Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol A Biol Sci Med Sci (2001) 1.52

Depressive symptoms of Alzheimer caregivers are mainly due to personal rather than patient factors. Int J Geriatr Psychiatry (1998) 1.51

Good nutritional oral intake is associated with equal survival in demented and nondemented very old patients. J Am Geriatr Soc (1996) 1.48

Effects of sensory aids on the quality of life and mortality of elderly people: a multivariate analysis. Age Ageing (1996) 1.43

Behavioral syndromes in Alzheimer's disease: description and correlates. Dement Geriatr Cogn Disord (1999) 1.37

Time-dependent changes in rat brain neuroactive steroid concentrations and GABAA receptor function after acute stress. Neuroendocrinology (1996) 1.36

Association between depressive symptoms and mortality in elderly people. Arch Intern Med (2001) 1.35

Trace element reference values in tissues from inhabitants of the European community. I. A study of 46 elements in urine, blood and serum of Italian subjects. Sci Total Environ (1990) 1.33

Ethanol markedly increases "GABAergic" neurosteroids in alcohol-preferring rats. Eur J Pharmacol (1999) 1.32

Contrasting results between caregiver's report and direct assessment of activities of daily living in patients affected by mild and very mild dementia: the contribution of the caregiver's personal characteristics. J Am Geriatr Soc (1999) 1.31

APOE-epsilon4 is associated with less frontal and more medial temporal lobe atrophy in AD. Neurology (1999) 1.30

Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Ann Neurol (1995) 1.29

Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients. Intensive Care Med (2008) 1.28

Secretory processing of amyloid precursor protein is inhibited by increase in cellular cholesterol content. Biochem J (1997) 1.27

Executive dysfunction in early Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 1.26

Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health (1995) 1.23

Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphology. Neuropharmacology (1974) 1.23

Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase-dependent pathway. FASEB J (2000) 1.23

Effectiveness of a cognitive rehabilitation program in mild dementia (MD) and mild cognitive impairment (MCI): a case control study. Arch Gerontol Geriatr (2007) 1.20

Are current biomarkers suitable for the assessment of manganese exposure in individual workers? Am J Ind Med (2000) 1.19

Calcium responses in fibroblasts from asymptomatic members of Alzheimer's disease families. Neurobiol Dis (1998) 1.18

Dopamine receptors: pharmacological and anatomical evidences indicate that two distinct dopamine receptor populations are present in rat striatum. Life Sci (1978) 1.17

Apolipoprotein E genotype and hippocampal asymmetry in Alzheimer's disease: a volumetric MRI study. J Neurol Neurosurg Psychiatry (2000) 1.16

Hippocampus and entorhinal cortex in frontotemporal dementia and Alzheimer's disease: a morphometric MRI study. Biol Psychiatry (2000) 1.16

Neuropsychological heterogeneity in mild Alzheimer's disease. Dementia (1994) 1.13

PI3K/AKT signaling determines a dynamic switch between distinct KSRP functions favoring skeletal myogenesis. Cell Death Differ (2011) 1.11

Association of the estrogen receptor alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun (1999) 1.08

Problems concerning the usefulness of adjustment of urinary cadmium for creatinine and specific gravity. Int Arch Occup Environ Health (1985) 1.08

Sensory impairments and mortality in an elderly community population: a six-year follow-up study. Age Ageing (1995) 1.07

Neuropsychiatric symptoms in amnestic and nonamnestic mild cognitive impairment. Dement Geriatr Cogn Disord (2007) 1.06

Addendum to 'Efficacy of music therapy treatment based on cycles of sessions: a randomised controlled trial' (Raglio et al., 2010). Aging Ment Health (2012) 1.06

Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol (1978) 1.05

Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia (1995) 1.05

Brain atrophy in frontotemporal dementia. J Neurol Neurosurg Psychiatry (1996) 1.04

The effect of chronic diseases on physical function. Comparison between activities of daily living scales and the Physical Performance Test. Age Ageing (1997) 1.03

Variations in the levels of the JAK/STAT and ShcA proteins in human brain tumors. Anticancer Res (1998) 1.03

Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples. Mol Neurobiol (1998) 1.01

STAT signalling in the mature and aging brain. Int J Dev Neurosci (2000) 1.01

LEIPAD, an internationally applicable instrument to assess quality of life in the elderly. Behav Med (1998) 1.00

Principal lifetime occupation and sleep quality in the elderly. Gerontology (1996) 1.00

Risk of mortality and institutionalization in demented patients with delusions. J Geriatr Psychiatry Neurol (1996) 1.00

Biological monitoring of occupational exposure to inorganic arsenic. Occup Environ Med (1999) 0.99

Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology (1993) 0.99

Brain magnetic resonance imaging and manganese exposure. Neurotoxicology (2000) 0.99

Italian community norms for the Brief Symptom Inventory in the elderly. Br J Clin Psychol (1993) 0.98

Amyloid precursor protein in platelets: a peripheral marker for the diagnosis of sporadic AD. Neurology (2001) 0.98

Immune infiltrates and cytokines in gliomas. Acta Neurochir (Wien) (1996) 0.98

The PKCbeta/HuR/VEGF pathway in diabetic retinopathy. Biochem Pharmacol (2010) 0.98

Apolipoprotein E epsilon 4 allele in Alzheimer's disease and vascular dementia. Dementia (1994) 0.96

Modulation of rat skeletal muscle chloride channels by activators and inhibitors of protein kinase C. Pflugers Arch (1991) 0.96

Akt2-mediated phosphorylation of Pitx2 controls Ccnd1 mRNA decay during muscle cell differentiation. Cell Death Differ (2009) 0.96

The role of anchoring protein RACK1 in PKC activation in the ageing rat brain. Trends Neurosci (1997) 0.96

Dopamine receptor sensitivity in brain and retina of rats during aging. Brain Res (1977) 0.96

Assessment of neurobehavioral performance as a function of current and cumulative occupational lead exposure. Neurotoxicology (2000) 0.96

Indicators of internal dose in current and past exposure to lead. Int Arch Occup Environ Health (1979) 0.96

Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res (1998) 0.96

A defective protein kinase C anchoring system underlying age-associated impairment in TNF-alpha production in rat macrophages. J Immunol (1999) 0.96

Dental status, quality of life, and mortality in an older community population: a multivariate approach. J Am Geriatr Soc (1997) 0.95

The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br J Pharmacol (1997) 0.95

Physical Performance Test and Activities of Daily Living scales in the assessment of health status in elderly people. J Am Geriatr Soc (1993) 0.95

[Research on the mechanism of inhibition of erythrocyte Na+-K+-ATPase by lead]. Med Lav (1969) 0.94

Na plus-K plus-ATPase activity of erythrocyte membranes: in urban populations not occupationally exposed to lead. Arch Environ Health (1973) 0.94

Consensus and variations in opinions on delirium care: a survey of European delirium specialists. Int Psychogeriatr (2013) 0.94

Basal ganglia precursors found in aggregates following embryonic transplantation adopt a striatal phenotype in heterotopic locations. Development (1998) 0.93

Defective phorbol ester-stimulated secretion of beta-amyloid precursor protein from Alzheimer's disease fibroblasts. Neurosci Lett (1995) 0.93

Community care for patients with Alzheimer's disease and non-demented elderly people: use and satisfaction with services and unmet needs in family caregivers. Int J Geriatr Psychiatry (1999) 0.93

Post-transcriptional regulation of HSP70 expression following oxidative stress in SH-SY5Y cells: the potential involvement of the RNA-binding protein HuR. Curr Pharm Des (2008) 0.92

Neurotoxicity in operating room personnel working with gaseous and nongaseous anesthesia. Int Arch Occup Environ Health (1996) 0.92

Clinical characteristics and risk factors of delirium in demented and not demented elderly medical inpatients. J Nutr Health Aging (2006) 0.92

Classification of calcium antagonists: proposal of the WHO Committee. Pharmacol Res Commun (1987) 0.92